Држава: Велика Британија
Језик: Енглески
Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aspirin
The Boots Company Plc
B01AC06
Aspirin
75mg
Gastro-resistant tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02090000; GTIN: 5045093773382
PACKAGE LEAFLET: INFORMATION FOR THE USER ASPIRIN 75MG GASTRO-RESISTANT TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor, or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What this medicine is and what it is used for 2. What you need to know before you take this medicine 3. How to take this medicine 4. Possible side effects 5. How to store this medicine 6. Contents of the pack and other information 1. WHAT THIS MEDICINE IS AND WHAT IT IS USED FOR • Aspirin belongs to a group of medicines called antiplatelet agents that help prevent your blood cells sticking together and forming a blood clot. • Aspirin 75mg Tablets are principally used to prevent blood clots forming following a heart attack or stroke or to help prevent heart attacks and strokes in patients who have previously suffered from these conditions. They may have been prescribed for you if you have recently had by-pass surgery. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE THIS MEDICINE DO NOT TAKE THIS MEDICINE: • if you are allergic to any of the ingredients of this medicine (listed in section 6) • are allergic to other salicylates or nonsteroidal anti-inflammatory drugs (NSAIDs).NSAIDs are often used for arthritis or rheumatism and pain • have had an asthma attack or swelling of some parts of the body e.g. face,lips, throat or tongue (angioedema) after taking salicylates or NSAIDs • if you have, or ever had, an ulcer in your stomach or intestine • if you have, or ever had, a bleed in your stomach or intestines (you may have bee Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aspirin 75mg Gastro-resistant Tablets Boots Aspirin75mg Gastro-resistant Tablets Lloyds Pharmacy Aspirin Enteric Coated Tablets 75mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains aspirin 75mg For the full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant tablet White circular tablet, plain on both sides. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY For the management of cardiovascular or cerebrovascular disease: The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75mg-150mg once daily. In some circumstances a higher dose may be appropriate, especially in the short term, and up to 300mg a day may be used on the advice of a doctor. In general, acetylsalicylic acids should be used with caution in elderly patients who are more prone to adverse events. The usual adult dose is recommended in the absence of severe renal or hepatic insufficiency (see sections 4.3 and 4.4). Treatment should be reviewed at regular intervals. Children: Aspirin 75mg Tablets is not indicated for use in children and young people less than 16 years of age (see 'Special Warnings and Precautions for Use'). METHOD OF ADMINISTRATION: Aspirin 75 mg is for oral administration to adults only. Take the tablet with water, do not cut, chew or crush the tablet. Swallow whole. 4.3. CONTRAINDICATIONS • Hypersensitivity to salicylic acid compounds or prostaglandin synthetase inhibitors (e.g. certain asthma patients who may suffer an attack or faint and certain patients who may suffer from bronchospasm, rhinitis and urticaria), to any of the excipients (see section 6.1) • Active, or history of recurrent peptic ulcer and/or gastric/intestinal haemorrhage, or other kinds of bleeding such as cerebrovascular Прочитајте комплетан документ